<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Albendazole: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Albendazole: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Albendazole: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11029" href="/d/html/11029.html" rel="external">see "Albendazole: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="13269" href="/d/html/13269.html" rel="external">see "Albendazole: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F130833"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Albenza [DSC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F130867"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Anthelmintic</li></ul></div>
<div class="block doa drugH1Div" id="F130835"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cd64f8fd-c063-4ffd-a2ab-bbb9c7551baa">
<i>Ancylostoma caninum</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Ancylostoma caninum </b></i>
<b>(eosinophilic enterocolitis)</b>
<b> (off-label use):</b>
<b>Oral:</b> 400 mg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0ff225da-c1d7-447a-89bb-5c4933c3c1c3">
<i>Ancylostoma duodenale</i> or <i>Necator americanus</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Ancylostoma duodenale</b></i>
<b> or </b>
<i>
<b>Necator americanus </b></i>
<b>(hookworms) (off-label use):</b>
<b>Oral:</b> 400 mg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013','lexi-content-ref-21980373']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013','lexi-content-ref-21980373'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d07d1a93-ec75-477a-b799-d47d02c84eb1">Ascariasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Ascariasis (intestinal roundworm) (off label): Oral:</b> 400 mg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="bf6125b5-7939-47ba-8f61-fbd2c6d6cfa6">
<i>Clonorchis sinensis</i> or <i>Opisthorchis viverrini</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Clonorchis sinensis </i> (Chinese liver fluke) or <i>Opisthorchis viverrini</i> (Southeast Asian liver fluke) (off-label use):</b>
<b>Oral:</b> 10 mg/kg/day for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a40cc1ad-6476-4227-8999-05d725a04e9d">Cutaneous larva migrans</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cutaneous larva migrans (dog and cat hookworm) (off-label use): Oral:</b> 400 mg once daily for 3 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ba54a6b8-42f6-4139-8dfb-cc8ab4fc1553">Enterobiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Enterobiasis <b>(pinworm) (off-label use)</b>:</b>
<b>Oral:</b> 400 mg as a single dose; repeat in 2 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1a7088e0-7d0f-47f9-85ee-4c73938d530d">Giardiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Giardiasis</b>
<i>
<b> (Giardia duodenalis</b></i>
<b>) </b>
<b>(alternative agent) (off-label use):</b>
<b>Oral:</b> 400 mg once daily for 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013','lexi-content-ref-15069729']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013','lexi-content-ref-15069729'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cd86396d-f8d0-45cd-a20d-13e5e27e38f5">Gnathostomiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Gnathostomiasis</b>
<i>
<b> (Gnathostoma spinigerum)</b></i>
<b> (off-label use):</b>
<b>Oral:</b> 400 mg twice daily for 21 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="62dceed1-787f-4740-960e-bb08c45075b5">Gongylonemiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Gongylonemiasis (<i>Gongylonema</i> spp.) (off-label use):</b>
<b>Oral:</b> 400 mg once daily for 3 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cbe93ec5-3ccc-4663-ae9e-162fb8dd821b">Hydatid disease</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hydatid disease </b>
<b>(<i>Echinococcus granulosis</i>, dog tapeworm)</b>
<b>:</b>
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">&lt;60 kg: 15 mg/kg/day in 2 divided doses (maximum: 800 mg/day).</p>
<p style="text-indent:-2em;margin-left:4em;">≥60 kg: 800 mg/day in 2 divided doses.</p>
<p style="text-indent:-2em;margin-left:4em;">Duration: Optimal duration uncertain; 1 to 6 months based on clinical factors (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cbad3130-67bf-45ea-94a7-601bfbbe4998">Microsporidiosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Microsporidiosis (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">Immunocompetent patients:</p>
<p style="text-indent:-2em;margin-left:6em;">Disseminated infection:<b> Oral:</b> 400 mg twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">Intestinal (<i>Encephalitozoon intestinalis</i>) infection: <b>Oral:</b> 400 mg twice daily for 21 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Ocular infection: <b>Oral:</b> 400 mg twice daily, in combination with topical fumagillin (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Immunocompromised patients (eg, patients with HIV):</p>
<p style="text-indent:-2em;margin-left:6em;">Disseminated or intestinal infection (other than <i>Enterocytozoon bieneusi</i> or <i>Vittaforma corneae</i>): <b>Oral:</b> 400 mg twice daily for 21 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-HHS.1','lexi-content-ref-31145496']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-HHS.1','lexi-content-ref-31145496'])">Ref</a></span>); for patients with HIV, continue until CD4 count &gt;200 cells/mm<sup>3</sup> for &gt;6 months after initiation of antiretroviral therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-HHS.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-HHS.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Ocular infection:<b> Oral:</b> 400 mg twice daily, in combination with topical fumagillin; continue until resolution of ocular symptoms and until CD4 count &gt;200 cells/mm<sup>3</sup> for &gt;6 months after initiation of antiretroviral therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-HHS.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-HHS.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="568141fd-b67d-41bf-a510-5a522d2d4be1">Neurocysticercosis, parenchymal disease</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Neurocysticercosis (<i>Taenia solium</i>, pork tapeworm), parenchymal disease:</b>
<b>Oral:</b> 15 mg/kg/day in 2 divided doses (maximum: 1.2 g/day) for 10 to 14 days; may be repeated if persistent viable lesions on 6-month follow-up imaging. <b>Note:</b> Concomitant therapy with praziquantel is recommended if &gt;2 viable cysts present (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24999157','lexi-content-ref-29790917','lexi-content-ref-34520139']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24999157','lexi-content-ref-29790917','lexi-content-ref-34520139'])">Ref</a></span>). Initiate adjunctive corticosteroid therapy prior to initiation of albendazole. Antiparasitic therapy should not be initiated in patients with untreated hydrocephalus, calcified lesions, or cysticercal encephalitis; consult an infectious diseases specialist for specific treatment recommendations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29790917']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29790917'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="535b14be-2f4b-4719-b13a-d7e847d2e396">
<i>Oesophagostomum bifurcum</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Oesophagostomum bifurcum</i> (off-label use):</b>
<b>Oral:</b> 400 mg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15228719']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15228719'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ae098320-33f8-49e5-86bd-3adab60a2caa">Taeniasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Taeniasis (alternative agent) (off label): Oral: </b>400 mg once daily for 3 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.4','lexi-content-ref-PAHO.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.4','lexi-content-ref-PAHO.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="236e7ba9-d840-4d21-88f1-4ba3a1d784c2">Toxocariasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Toxocariasis (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Ocular larva migrans with sight-threatening ocular inflammation:</i></b>
<b>Oral:</b> Optimal dose is unknown: 400 mg twice daily for 2 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25564736']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25564736'])">Ref</a></span>); 800 mg twice daily has also been described (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11436948']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11436948'])">Ref</a></span>). Give with concomitant corticosteroids (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11436948','lexi-content-ref-25564736']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11436948','lexi-content-ref-25564736'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Visceral larva migrans, moderate to severe: </i>Oral:</b> 400 mg twice daily generally for 5 days; consider concomitant corticosteroids for severe infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8ef18494-a990-43af-8b22-1f2dc90f8d98">Trichinellosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Trichinellosis (<i>Trichinella spiralis</i>) (off-label use):</b>
<b>Oral:</b> 400 mg twice daily for 8 to 14 days; concomitant corticosteroids may be given for severe symptoms (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991289"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling (has not been studied). However, the need for adjustment not likely since albendazole is primarily eliminated by hepatic metabolism. </p></div>
<div class="block doha drugH1Div" id="F50988603"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer's labeling. However, patients with underlying liver disease may be more at risk for adverse effects.</p></div>
<div class="block doe drugH1Div" id="F130836"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F130850"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="13269" href="/d/html/13269.html" rel="external">see "Albendazole: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="bc7e00e9-9406-4def-96c2-06d4cb04b171">Ascariasis [intestinal roundworm]</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Ascariasis (intestinal roundworm):</b> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Children &lt;2 years: Oral: 200 to 400 mg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5','lexi-content-ref-12745139','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5','lexi-content-ref-12745139','lexi-content-ref-AAP.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥2 years and Adolescents: Oral: 400 mg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="34edc772-c3ab-4c32-90fe-f2f1458e102a">
<i>Baylisascaris procyonis</i>, postexposure prophylaxis and treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Baylisascaris procyonis </i>(raccoon roundworm), postexposure prophylaxis and treatment:</b> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 20 to 50 mg/kg/day in a single dose or 2 divided doses <b>or</b> 400 mg twice daily for 10 to 20 days. Longer duration (eg, 3 to 4 weeks) has also been described. Initiate as soon as possible after potential exposure (ideally within 3 days) to prevent clinical disease in any child at risk (eg, ingestion of raccoon stool or contaminated soil) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.6','lexi-content-ref-12394823','lexi-content-ref-36046372','lexi-content-ref-26960940','lexi-content-ref-21119798','lexi-content-ref-15546085','lexi-content-ref-17553240','lexi-content-ref-11015551','lexi-content-ref-22311989','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.6','lexi-content-ref-12394823','lexi-content-ref-36046372','lexi-content-ref-26960940','lexi-content-ref-21119798','lexi-content-ref-15546085','lexi-content-ref-17553240','lexi-content-ref-11015551','lexi-content-ref-22311989','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="4de4059e-fa73-431d-88e6-d24677189ef0">Capillariasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Capillariasis:</b> Limited data available: Children and Adolescents: Oral: 400 mg once daily for at least 10 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.8','lexi-content-ref-AAP.2','lexi-content-ref-10548302']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.8','lexi-content-ref-AAP.2','lexi-content-ref-10548302'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e0f2c92e-5519-4755-9352-a910f84be241">Enterobiasis [pinworm]</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Enterobiasis</b>
<b> (pinworm)</b>: Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Children &lt;2 years: Oral: 200 mg as a single dose; may repeat in 2 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.7','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.7','lexi-content-ref-AAP.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥2 years and Adolescents: Oral: 400 mg as a single dose; repeat in 2 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.2','lexi-content-ref-3516398','lexi-content-ref-4028809','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.2','lexi-content-ref-3516398','lexi-content-ref-4028809','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1a7088e0-7d0f-47f9-85ee-4c73938d530d">Giardiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Giardiasis </b>
<b>(<i>Giardia duodenalis</i></b>) (alternative therapy): Limited data available: Children ≥2 years and Adolescents: Oral: 10 to 15 mg/kg/dose once daily for 5 to 10 days; maximum dose: 400 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.2','lexi-content-ref-15191380']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.2','lexi-content-ref-15191380'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1983b52c-0abb-4302-bce5-8ede58d479e3">Gnathostomiasis, cutaneous</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Gnathostomiasis, cutaneous:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Limited data available: Oral: 400 mg twice daily for 21 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.11','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.11','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="65b7daa7-08a3-48e7-ae7a-d84cbce55ddd">Hookworm-related cutaneous larva migrans</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hookworm-related cutaneous larva migrans (<i>Ancylostoma braziliense, Ancylostoma caninum, Ancylostoma ceylanicum, Uncinaria stenocephala</i>):</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥2 months and Children ≤2 years: Very limited data available: Oral: 15 mg/kg/dose once daily for 3 days; maximum dose: 200 mg/dose. Dosing based on case reports; some patients ≥8 months of age received fixed doses of 200 mg/dose and in one case the dosing was split into two divided doses (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21198527','lexi-content-ref-26538729','lexi-content-ref-24278060','lexi-content-ref-30231902','lexi-content-ref-30959248']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21198527','lexi-content-ref-26538729','lexi-content-ref-24278060','lexi-content-ref-30231902','lexi-content-ref-30959248'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children &gt;2 years and Adolescents: Limited data available: Oral: 15 mg/kg/dose once daily for 3 days; maximum dose: 400 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.2','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.2','lexi-content-ref-AAP.2'])">Ref</a></span>). Fixed dosing of 400 mg once daily for 3 days has also been recommended (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.16','lexi-content-ref-WHO.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.16','lexi-content-ref-WHO.5'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="89a4b2cb-a7dd-498c-8a6d-aded411e206a">Hookworms, human</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hookworms, human (<i>Ancylostoma duodenale</i></b>
<b> or </b>
<b>
<i>N. americanus</i>)</b>
<b>:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥3 months: Very limited data available: Oral: 200 mg as a single dose. Dosing based on two cases (patient #1: age: 12 weeks, weight: 4.2 kg; and patient #2: age: 8 months, weight: 5.8 kg) of exclusively breastfed infants who showed clinical improvement after single-dose albendazole therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20228435']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20228435'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children &lt;2 years: Limited data available: Oral: 200 to 400 mg as a single dose; may repeat in 3 weeks if needed (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.2','lexi-content-ref-12745139','lexi-content-ref-AAP.2','lexi-content-ref-WHO.1','lexi-content-ref-WHO.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.2','lexi-content-ref-12745139','lexi-content-ref-AAP.2','lexi-content-ref-WHO.1','lexi-content-ref-WHO.5'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥2 years and Adolescents: Limited data available: Oral: 400 mg as a single dose; may repeat in 3 weeks if needed (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.2','lexi-content-ref-AAP.2','lexi-content-ref-WHO.1','lexi-content-ref-WHO.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.2','lexi-content-ref-AAP.2','lexi-content-ref-WHO.1','lexi-content-ref-WHO.5'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8b18dda0-a242-4cef-b26d-7b9d515b2194">Hydatid disease [<i>Echinococcus granulosus</i>, dog tapeworm]</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hydatid disease (<i>E. granulosus</i>, dog tapeworm):</b> Children and Adolescents: Oral: 5 to 7.5 mg/kg/dose twice daily for 1 to 6 months; maximum dose: 400 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.10','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.10','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="17b42cb1-0e7f-486b-ac59-58a5f8d557b4">Liver flukes</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Liver flukes (<i>Clonorchiasis</i> or <i>Opisthorchiasis</i>)</b> (alternative therapy): Limited data available: Children and Adolescents: Oral: 10 mg/kg/dose once daily for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.9','lexi-content-ref-CDC.13','lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.9','lexi-content-ref-CDC.13','lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="2976a2bf-88eb-455c-864e-a6865f678a27">Loiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Loiasis: </b>Children and Adolescents: Limited data available: Oral: 200 mg twice daily for 21 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.12','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.12','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0d289a39-0766-4143-9ff1-c6a1eaeb8cd5">
<i>Microsporidia</i> infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Microsporidia</i> infection: </b>Limited data available: <b>Note: </b>Limited or no efficacy against <i>Enterocytozoon spp.</i> (eg, <i>Enterocytozoon bieneusi</i>) or <i>Vittaforma corneae </i>(<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11498405','lexi-content-ref-HHS.4']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11498405','lexi-content-ref-HHS.4'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 7.5 mg/kg/dose twice daily; maximum dose: 400 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31145496','lexi-content-ref-HHS.4','lexi-content-ref-AAP.2','lexi-content-ref-15602190']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31145496','lexi-content-ref-HHS.4','lexi-content-ref-AAP.2','lexi-content-ref-15602190'])">Ref</a></span>). Duration of therapy is not well established but should be individualized based on immune status, site of infection (localized or disseminated), and clinical response; 2 to 4 weeks has been suggested, though 7 days of therapy may be adequate in immunocompetent patients with infection limited to the GI tract. In patients with HIV, continue until resolution of signs and symptoms and sustained immune reconstitution (&gt;6 months at CDC immunologic category 1 or 2) after antiretroviral therapy initiation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31145496','lexi-content-ref-11498405','lexi-content-ref-34190570','lexi-content-ref-HHS.4','lexi-content-ref-15602190']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31145496','lexi-content-ref-11498405','lexi-content-ref-34190570','lexi-content-ref-HHS.4','lexi-content-ref-15602190'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="568141fd-b67d-41bf-a510-5a522d2d4be1">Neurocysticercosis, parenchymal disease</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Neurocysticercosis (<i>T. solium,</i> pork tapeworm), parenchymal disease: Note:</b> Patients should receive concurrent corticosteroid for the first week of albendazole therapy and antiseizure medication therapy as required. If &gt;2 viable cysts present, combination therapy with praziquantel is recommended (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29790917','lexi-content-ref-AAP.2','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29790917','lexi-content-ref-AAP.2','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 7.5 mg/kg/dose twice daily for 10 to 14 days; maximum dose: 600 mg/dose. Treatment for up to 30 days has also been recommended (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29790917','lexi-content-ref-AAP.2','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29790917','lexi-content-ref-AAP.2','lexi-content-ref-manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6086086e-e5a8-4ad4-aff6-900b5be98045">Strongyloidiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Strongyloidiasis (<i>S. stercoralis</i>)</b> (alternative agent): Limited data available: Children and Adolescents: Oral: 400 mg twice daily for 7 days; patients with hyperinfection and disseminated disease may need prolonged or repeated treatment (eg, daily treatment until stool and/or sputum exams are negative for 2 weeks) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31145496','lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31145496','lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="236e7ba9-d840-4d21-88f1-4ba3a1d784c2">Toxocariasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Toxocariasis: </b>Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 400 mg twice daily. Treatment for 5 days is recommended; however, optimal treatment duration unknown. Treatment for ocular larva migrans has been reported for up to 2 to 4 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11436948','lexi-content-ref-CDC.14','lexi-content-ref-19329060','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11436948','lexi-content-ref-CDC.14','lexi-content-ref-19329060','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8ef18494-a990-43af-8b22-1f2dc90f8d98">Trichinellosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Trichinellosis (<i>Trichinosis</i>):</b> Limited data available: Children and Adolescents: Oral: 400 mg twice daily for 8 to 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.15','lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2','lexi-content-ref-WHO.5']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.15','lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2','lexi-content-ref-WHO.5'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6d093459-b3fa-4ed1-b552-5b794d677194">Trichuriasis [whipworm]</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Trichuriasis (whipworm): </b>Limited data available: Children and Adolescents: Oral: 400 mg once daily for 3 days; heavy infestations may be treated for 5 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-MedLet.2013','lexi-content-ref-AAP.2'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51063425"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling (has not been studied). However, the need for adjustment not likely since albendazole is primarily eliminated by hepatic metabolism.</p></div>
<div class="block dohp drugH1Div" id="F51063426"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; consider discontinuing therapy if hepatic enzymes increase to twice the ULN while on therapy based on patient clinical status.</p></div>
<div class="block adr drugH1Div" id="F130806"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;">&gt;10%: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Headache (neurocysticercosis: 11%; hydatid: 1%)  </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Hepatic: Increased liver enzymes (hydatid: 16%; neurocysticercosis: &lt;1%) </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">1% to 10%: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Increased intracranial pressure (≤2%), dizziness (≤1%), vertigo (≤1%), meningism (1%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dermatologic: Alopecia (&lt;1% to 2%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gastrointestinal: Abdominal pain (≤6%), nausea and vomiting (4% to 6%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Miscellaneous: Fever (≤1%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">&lt;1%, postmarketing, and/or case reports: Acute hepatic failure, acute renal failure, agranulocytosis, aplastic anemia, erythema multiforme, granulocytopenia, hepatitis, hypersensitivity reaction, leukopenia, neutropenia, pancytopenia, skin rash, Stevens-Johnson syndrome, thrombocytopenia, urticaria </p></div>
<div class="block coi drugH1Div" id="F130817"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to albendazole, benzimidazoles, or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F130803"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Bone marrow suppression: Agranulocytosis, aplastic anemia, granulocytopenia, leukopenia, and pancytopenia have occurred leading to fatalities (rare); use with caution in patients with hepatic impairment (more susceptible to hematologic toxicity). Discontinue therapy in all patients who develop clinically significant decreases in blood cell counts.</p>
<p style="text-indent:-2em;margin-left:4em;">• Transaminase elevations: Reversible elevations in hepatic enzymes have been reported. Patients with abnormal LFTs and hepatic echinococcosis are at an increased risk of hepatotoxicity. Discontinue therapy if LFT elevations are &gt;2 times the upper limit of normal; may consider restarting treatment (with frequent monitoring of LFTs) when hepatic enzymes return to pretreatment values. Discontinue therapy if hepatic enzymes are significantly increased.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Neurocysticercosis: Appropriate use: Antiparasitic therapy may worsen symptoms of neurocysticercosis by inducing an inflammatory response; adjunctive corticosteroid therapy should be started before initiation of albendazole. Antiparasitic therapy should not be initiated in patients with untreated hydrocephalus, calcified lesions, or cysticercal encephalitis. Perform funduscopic exam prior to initiation of antiparasitic therapy to exclude intraocular cysticerci; antiparasitic therapy may lead to blindness in some cases with unsuspected intraocular parasites (IDSA/ASTMH [White 2018]).</p></div>
<div class="block foc drugH1Div" id="F130812"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Albenza: 200 mg [DSC]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Albenza: 200 mg [DSC] [contains saccharin sodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 200 mg</p></div>
<div class="block geq drugH1Div" id="F130799"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F130819"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Albendazole Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">200 mg (per each): $18.00 - $276.65</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F130814"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Oral: Administer with a high-fat meal if treating a systemic infection (to increase absorption). Administration on an empty stomach may be appropriate for treating an intraluminal infection with no systemic involvement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-3396623']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-3396623'])">Ref</a></span>). If patients have difficulty swallowing, tablets may be crushed or chewed, then swallowed with a drink of water.</p></div>
<div class="block admp drugH1Div" id="F52612188"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: Administer with a high-fat meal to increase absorption. For patients who have difficulty swallowing whole tablets, tablet may be crushed or chewed and swallowed with a drink of water.</p></div>
<div class="block use drugH1Div" id="F130813"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Hydatid disease (<i>Echinococcus granulosus</i>, dog tapeworm):</b> Treatment of cystic hydatid disease of the liver, lung, and peritoneum caused by the larval form of the dog tapeworm, <i>E. granulosus</i>.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Neurocysticercosis (<i>Taenia solium</i>, pork tapeworm), parenchymal disease:</b> Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, <i>T. solium</i>.</p></div>
<div class="block off-label drugH1Div" id="F25708398"><span class="drugH1">Use: Off-Label: Adult</span><p>Ancylostoma caninum (eosinophilic enterocolitis); Ancylostoma duodenale or Necator americanus (hookworms); Ascariasis (intestinal roundworm); Clonorchis sinensis (Chinese liver fluke) or Opisthorchis viverrini (Southeast Asian liver fluke); Cutaneous larva migrans (dog and cat hookworm); Enterobiasis (pinworm); Giardiasis (Giardia duodenalis); Gnathostomiasis (Gnathostoma spinigerum); Gongylonemiasis (Gongylonema spp.); Microsporidiosis; Oesophagostomum bifurcum; Toxocariasis; Trichinellosis (Trichinella spiralis)</p></div>
<div class="block mst drugH1Div" id="F3195081"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Albenza may be confused with Aplenzin, Relenza.</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">International issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Albenza [US] may be confused with Avanza brand name for mirtazapine [Australia].</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F130860"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">
<b>Substrate</b> of CYP1A2 (minor), CYP3A4 (minor); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>
<div class="block dri drugH1Div" id="F130807"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">CarBAMazepine: May decrease serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Grapefruit Juice: May increase serum concentrations of the active metabolite(s) of Albendazole. Specifically, concentrations of albendazole sulfate may be increased.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Nirmatrelvir and Ritonavir: May decrease the serum concentration of Albendazole.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">PHENobarbital: May decrease serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Phenytoin: May decrease serum concentrations of the active metabolite(s) of Albendazole.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ritonavir: May decrease the serum concentration of Albendazole.<i> Risk C: Monitor therapy</i></p></div>
<div class="block foi drugH1Div" id="F130829"><span class="drugH1">Food Interactions</span>
<p style="text-indent:0em;display:inline">Albendazole serum levels may be increased if taken with a fatty meal (increases the oral bioavailability by up to 5 times). Management: Should be administered with a high-fat meal when treating systemic infections.</p></div>
<div class="block rep_considerations drugH1Div" id="F49042600"><span class="drugH1">Reproductive Considerations</span>
<p style="text-indent:0em;">Evaluate pregnancy status prior to use in females of reproductive potential. Effective contraception is recommended during chronic therapy (Persichino 2018) and for 1 month after the last dose (per the manufacturer).</p>
<p style="text-indent:0em;margin-top:2em;">The World Health Organization recommends preventive therapy with a benzimidazole, such as albendazole, in females of reproductive potential who live in areas where the baseline prevalence of soil-transmitted helminth infections is ≥20% (WHO 2017).</p></div>
<div class="block pri drugH1Div" id="F130820"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Information following first trimester use of albendazole is limited (Gyorkos 2019; Lau 2020). Most pregnancy outcome information is available from studies using a single dose of albendazole administered to women during the second or third trimester (Gyorkos 2019; Lau 2020; Mofid 2017; Salam 2015). However, case reports are also available following longer term treatment of hydatid disease (Auer 1994; Bhattacharyya 2013; Pallua 2010).</p>
<p style="text-indent:0em;margin-top:2em;">Untreated soil-transmitted helminth infections during pregnancy are associated with adverse maternal outcomes (eg, maternal iron deficiency anemia, impaired nutrient absorption) (WHO 2017).</p>
<p style="text-indent:0em;margin-top:2em;">Use during the first trimester of pregnancy is not recommended (HHS [OI Adult 2019]; IDSA/ASTMH [White 2018]; WHO 1996; WHO 2017). Pregnant patients with neurocysticercosis should be treated for symptoms (eg, increased intracranial pressure, seizures) the same as nonpregnant patients; however, antihelminthic therapy with albendazole can be deferred until after delivery (IDSA/ASTMH [White 2018]). Albendazole should not be used for the treatment of microsporidiosis in HIV-infected pregnant patients during the first trimester; use later in pregnancy may be considered when the benefits outweigh potential risks (HHS [OI Adult 2019]; White 2018). The WHO also recommends treatment of soil-transmitted helminthiases (such as hookworm) in pregnant patients after the first trimester (WHO 1996). Pregnant women arriving as refugees from specific countries should not be given albendazole for the presumptive treatment of intestinal parasites prior to arrival in the United States (CDC 2019a).</p></div>
<div class="block brc drugH1Div" id="F20519483"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Albendazole is present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;">Albendazole excretion into breast milk was studied following a single oral 400 mg dose in breastfeeding women 2 weeks' to 6 months' postpartum (n=33). Mean albendazole concentrations 6 hours after the dose were 63.7 ± 11.9 ng/mL (maternal serum) and 31.9 ± 9.2 ng/mL (milk). An active and inactive metabolite were also detected in breast milk (Abdel-tawab 2009).</p>
<p style="text-indent:-2em;margin-left:2em;">A case report describes use of albendazole for the treatment of hydatid disease of the breast in a lactating woman (Siddiqui 2015).</p>
<p style="text-indent:-2em;margin-left:2em;">According to the manufacturer, the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother. However, albendazole is generally considered compatible with breastfeeding (WHO 2002). Breastfeeding women arriving as refugees from specific countries may be given albendazole for the presumptive treatment of intestinal parasites (CDC 2019a).</p></div>
<div class="block mop drugH1Div" id="F130810"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:-2em;margin-left:2em;">LFTs and CBC with differential at start of each 28-day cycle and every 2 weeks during therapy (more frequent monitoring for patients with liver disease); pregnancy test</p>
<p style="text-indent:-2em;margin-left:4em;">Patients with neurocysticercosis: Ophthalmic exam for retinal lesions prior to therapy initiation; MRI every 6 months after completing therapy until resolution of cystic lesion (IDSA/ASTMH [White 2018])</p></div>
<div class="block pha drugH1Div" id="F130802"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Active metabolite, albendazole sulfoxide, causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired, and desecratory substances accumulate intracellulary. ATP production decreases causing energy depletion, immobilization, and worm death.</p></div>
<div class="block phk drugH1Div" id="F130816"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note:</b> In pediatric patients (6 to 13 years), pharmacokinetic values were reported to be similar to adult data.</p>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Poor from the GI tract; may increase up to 5 times when administered with a fatty meal.</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Widely distributed throughout the body including urine, bile, liver, cyst wall, cyst fluid, and CSF.</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: 70%.</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Hepatic; extensive first-pass effect; pathways include rapid sulfoxidation to active metabolite (albendazole sulfoxide [major]), hydrolysis, and oxidation.</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: 8 to 12 hours (albendazole sulfoxide).</p>
<p style="text-indent:-2em;margin-left:2em;">Time to peak, serum: 2 to 5 hours for the metabolite.</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (&lt;1% as active metabolite); feces.</p></div>
<div class="block phksp drugH1Div" id="F51219914"><span class="drugH1">Pharmacokinetics: Additional Considerations (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Hepatic function impairment: Systemic availability, rate of absorption, and the elimination half-life of albendazole sulfoxide are increased in patients with extrahepatic obstruction.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F130822"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Albenda | Zentel</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Nematel | Vastus | Vermicet | Vermizole</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Abentel | Adze | Al | Al-Ds | Alba | Albazole | Alben | Albenda | Albizol | Alda ds | Alentin | Almex | Almin | Alzed | Alzen | Alzol | Biben | Chuben | Eben-DS | Estazol | Kiltel | Luban | Monoben | Qben ds | Sintel | Triben | Vermid | Zoben</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Alben | Albendazole tm | Albentox | Albizol | Alzol | Calben | G abzole | Licdazol | Q worm | Verzil | Verzol | Zentel</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Albel | Albendal | Albendazol | Albendrox | Albentel | Albenzonil | Alib | Alzoben | Benzol | Mebenix | Monozol | Neo bendazol | Parazol | Totelmin | Verdazol | Vermiclase | Vermital | Zolben | Zoldan</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Abz | Alben | Albentox | Albex | Albizol | Asbenzol | Azole | Bendex | G abzole | Lyben | Mezol | Parazol | Saniver | Veriben | Zaben | Zentel | Zobend | Zobenol</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Abentel | Zentel</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Alben-trex | Albendazol | Albendazol mk | Aldrizol | Almezol | Amezolin | Analon | Ascarzol | Ciclopar | Crysthoidex | Elipar | Famidox | Finapar | Helminzol | Killary | Kyllary | Labendazol | Lisipar | Maxpar | Obedozol | Oxofor | Rotopar | Seldem | Suifazol | Targan | Zentel | Zimpar | Zopirack</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Albendazol vim spectrum | Zentel</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Alben | Albendazol | Albendazol Calox | Albendazol iberofarmaco | Albenzol | Aldamin | Aldezol | Alzol | Apardu | Avadyl | Conssel | Corcen | E.P.E | Ethizol | Fradazol | Kilpar | Krip | Oxarmin | Quizol | Suifazol | Tiroben | Uniben | Unizol | Vermintel | Xadem | Zentel | Zooid</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Albendazol | Albendazol Genfar | Albendazol mk | Albenstar | Ascarol | Fagol | H.G. Alben | Italbenzol | Librabendazol | Tazep | Vermigen</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Albendazol | Albenza | Andazol | Eskazole</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Alzental | Antizole | Vermizole</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Corzole | Helmadol | Nubend | Zestaval</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Albendazole Dci | Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Albendazol phama vim | Zentel</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Albendazol | Helben | Zentel</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Abd | Abide | Abwal | Abz | Acizole | Al | Alb | Alba | Albact | Albazole | Alben | Albendol | Albenum | Albest | Albezole | Albol | Albrodo | Albus | Aldezole | All-in-1 | Alminth | Altec | Alzad | Anoworm | Bandy | Be-dol | Ben | Bendacid | Benrod | Bentel | Benz | Benzol | Beworm | Biwom | Cidazole | Curezole | Dehel | Dispel | E-worm | Ejectil | Ejectil p | Elben | Elbend | Elbenol | Eldoben | Elminex | Emanthal | Enbenol | Eraworm | Gekare | Helmex | Krumex | Lyben | Mahabend | Mediminth | Milibend | Morband | Neomin | Nopar | Noworm | Odal | Olworm | Omnitel | Panamint | Pentacid | Pentanil | Saf-a | Sanzole | Sidose | Sp worm | Syband | Thelmin | Tiobend | Toko | Ulben | Vanke | Verban | Vermitel | Vormout | Womiban | Wormfix | Wormin-a | Wormitel | Wormpel | Wormtab | Wornil | Xenda | Xenith | Xeroworm AD | Zelbend | Zentel | Zondal | Zybend</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Cystazole</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Abz | Albasol | Albemed | Alben | Albendol | Albenipro | Alphin ds | Altoa | Azole | Benaworm | Bendex | Elyzole | G abzole | Nubend | Tanzol | Wombit | Womiban | Wooban | Wormpel | Zeben</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Alben | Alben free zole | Albenda | Albendazole daewoong | Albentel | Albenzole | Alberin | Albi | Albicel | Alcandazole | Allbacom | Allbis | Allis | Allssak | Allzental | Alnazol | Alpina | Alpon | Alssak | Alzental | Alzole | Boryung albendazole | Ckd albendazole | Dazole | Dongkoo albendazole | Genitel | Iksu albenzole | Ilyangbio albendazole | Jeil albendazole | Jenacom | Jr albendazole | Kebendazole | Kwangdong albendazole | Moazol | Neobenzole | Onetel | Orwon | Ovis | Rallybenda | Shuben | Suben | Windazole | Wonazole | Zentalon | Zentazole | Zentel | Zentrax</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Albenda</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Albenda | Andazol | Bendax | Zentel</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Albendazol | Andazol | Duador | Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Andazol | Duador | Eskazol | Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Azole | Verzol | Zentel</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Albendazol | Albendazol bioresearch | Albendazol gi prot | Albendazol Hormona | Albensil | Aldamin | Bendapar | Bradelmin | Bruzol | Buxol | Dazocan | Entoplus | Eskazole | Flatezol | Gascop | Helmison s | Kolexan | Loveral | Lurdex | Olbendital | Vermilan | Vermin-plus | Vermisen | Xermixil | Zenaxin | Zentel</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Albendol | Denzol | Thelban | Vemizol | Zendal | Zentel | Zoben</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Albe f albendazole | Albemed | Antel | Aphazole | Ascantel | Avis | Balzole | Chemtel | Cibendazole | Clarion albendazole | Cystazole | Danzel | Expezol | G abzole | Greatlight albendazole | Jekzol | Krisdazole | Lordazole | Marco | Nci albendazole | Sam albendazole | Synbate | Tamar &amp; pharez albendazole | Ugolife albendazole | Ultiworm | Wormidan | Xtal | Zarra | Zentel | Zestazole | Zolat | Zyroben | Zzatab</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Eskazole</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Alben | Albendaken | Albendazol | Cental | Ceprazol | Parasitel | Zentel</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Aldazol | Zentel</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Alba | Albazole | Alben | Albendo | Alenda | Aliz | Alovac | Alza | Benda | Desite | Larex | Nenzole | Verid | Worcyt | Wormed | Wormgo | Wormocid | Xedol | Zavic | Zentel | Zentmaf | Zepar</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Albenza</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Albendazol prosalud | Aterosol | Daxol plus | Lesmin a | Pantex</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Albenda | Andazol | Zentel</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Albendazol lph | Albendazol vim spectrum | Albendol | Duador | Eskazole | Vermigal novo | Zentel</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Gelmodol vm | Nemozol</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Albenda | Vermizole</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Alzental | Zentel</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Dalben | Eskazole | Zentel</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(SL)</span> <span class="country">Sierra Leone</span><span class="countrySeparator">: </span><span class="drugName">Albezol | Veetel | Welworm | Wormzap | Zeben | Zentel | Zolat</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Albatel | Albega | Albemed | Alben | Alben Hero | Albenda | Albenz | Albezol | Aldazole | Alfuca | Alzol | Antheda | Anthel | Azil | Benvatel | Benyad | Enmed | Erasit | Falben | Fatel | Gendazel | Goose Ben | Labenda | Leo 400 | Manozide | Medazde | Mesin | Pipalben | Q worm | San San | Startel | Vermixide | Vetoben | Zalben | Zeben | Zela</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Nemacest | Zentel</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Andazol</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Zentel</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Albela | Albendazole pharmex | Aldazol | Nemozol</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Albasol | Alzol | Bendas | Elyzole | Vermikil | Verzol | Zeben | Zepar</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Helmiben</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Albendazol | Albendazol mf | Albicar | Bevindazol | Helal | Nadoxin | Sostril | Vendazol | Zentel</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Albenca | Farica | Larzole | Mekozetel | Vinfuca</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Bendex | Wormadole | Zentel</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Alben | G abzole | Nubend | Tanzol | Unibazole | Wormin-a | Zentel</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Abz | Anthel</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-Albendazole.1">
<a name="Albendazole.1"></a>Albendazole tablets [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc; May 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Albenza.1">
<a name="Albenza.1"></a>Albenza (albendazole) tablets [prescribing information]. Bridgewater, NJ: Amneal Pharmaceuticals LLC; September 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19916998">
<a name="19916998"></a>Abdel-tawab AM, Bradley M, Ghazaly EA, et al, "Albendazole and its Metabolites in the Breast Milk of Lactating Women Following a Single Oral Dose of Albendazole,"<i> Br J Clin Pharmacol</i>, 2009, 68(5):737-42.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/19916998/pubmed" id="19916998" target="_blank">19916998</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.2">
<a name="AAP.2"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. <i>Red Book: 2021 Report of the Committee on Infectious Diseases</i>. 32nd ed. American Academy of Pediatrics; 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8087155">
<a name="8087155"></a>Auer H, Kollaritsch H, Jüptner J, Aspöck H. Albendazole and pregnancy. <i>Appl Parasitol</i>. 1994;35(2):146-147.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/8087155/pubmed" id="8087155" target="_blank">8087155</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23568997">
<a name="23568997"></a>Baird RA, Wiebe S, Zunt JR, et al, “Evidence-Based Guideline: Treatment of Parenchymal Neurocysticercosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology,” <i>Neurology</i>, 2013, 80(15):1424-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/23568997/pubmed" id="23568997" target="_blank">23568997</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11436948">
<a name="11436948"></a>Barisani-Asenbauer T, Maca SM, Hauff W, et al. Treatment of ocular toxocariasis with albendazole. <i>J Ocul Pharmacol Ther</i>. 2001;17(3):287-294. doi: 10.1089/108076801750295317.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/11436948/pubmed" id="11436948" target="_blank">11436948</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16679166">
<a name="16679166"></a>Bethony J, Brooker S, Albonico M, et al, “Soil-Transmitted Helminth Infections: Ascariasis, Trichuriasis, and Hookworm,” <i>Lancet</i>, 2006, 367(9521):1521-32.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/16679166/pubmed" id="16679166" target="_blank">16679166</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20228435">
<a name="20228435"></a>Bhatia V, Das MK, Kumar P, Arora NK. Infantile hookworm disease. <i>Indian Pediatr</i>. 2010;47(2):190-192.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/20228435/pubmed" id="20228435" target="_blank">20228435</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23625356">
<a name="23625356"></a>Bhattacharyya SK, Bhattacharya S, Alam H, Patua B, Chattopadhyay P. Dilemmas encountered while dealing a pregnancy complicated by pelvic Hydatid disease. <i>Arch Gynecol Obstet</i>. 2013;288(5):965-966.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/23625356/pubmed" id="23625356" target="_blank">23625356</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21198527">
<a name="21198527"></a>Black MD, Grove DI, Butcher AR, Warren LJ. Cutaneous larva migrans in infants in the Adelaide Hills. <i>Australas J Dermatol</i>. 2010;51(4):281-284.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/21198527/pubmed" id="21198527" target="_blank">21198527</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bradley.2">
<a name="Bradley.2"></a>Bradley JS, Nelson JD, Kimberlin DK, et al, eds. <i>Nelson's Pediatric Antimicrobial Therapy</i>. 29th ed. American Academy of Pediatrics; 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.1">
<a name="CDC.1"></a>Centers for Disease Control and Prevention (CDC) parasite website. <a href="https://www.cdc.gov/parasites/index.html" target="_blank">https://www.cdc.gov/parasites/index.html</a>. Accessed November 11, 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.2">
<a name="CDC.2"></a>Centers for Disease Control and Prevention (CDC). Parasites - Cysticercosis. Available at <a href="https://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html#drugs" target="_blank">http://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html#drugs</a>. Updated April 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19730409">
<a name="19730409"></a>Centers for Disease Control and Prevention (CDC). Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. <i>MMWR Recomm Rep.</i> 2009;58(RR-11):1-166.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/19730409/pubmed" id="19730409" target="_blank">19730409</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.3">
<a name="CDC.3"></a>Centers for Disease Control and Prevention (CDC). Guidelines for overseas presumptive treatment of strongyloidiasis, schistosomiasis, and soil-transmitted helminth infections for refugees resettling to the United States. February 2019a. <a href="https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/intestinal-parasites-overseas.html" target="_blank">https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/intestinal-parasites-overseas.html</a>.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.4">
<a name="CDC.4"></a>Centers for Disease Control and Prevention (CDC). Parasites. <a href="https://www.cdc.gov/parasites/index.html" target="_blank">https://www.cdc.gov/parasites/index.html</a>. Updated August 19, 2022. Accessed August 31, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.5">
<a name="CDC.5"></a>Centers for Disease Control and Prevention (CDC). Parasites - Ascariasis. <a href="https://www.cdc.gov/parasites/ascariasis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/ascariasis/health_professionals/index.html</a>. May 20, 2020a. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.6">
<a name="CDC.6"></a>Centers for Disease Control and Prevention (CDC). Parasites - Baylisascaris infection. <a href="https://www.cdc.gov/parasites/baylisascaris/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/baylisascaris/health_professionals/index.html</a>. Updated August 28, 2019b. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.8">
<a name="CDC.8"></a>Centers for Disease Control and Prevention (CDC). Parasites - Capillariasis (also known as <i>Capillaria</i> infection). <a href="https://www.cdc.gov/parasites/capillaria/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/capillaria/health_professionals/index.html</a>. Updated May 20, 2020b. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.9">
<a name="CDC.9"></a>Centers for Disease Control and Prevention (CDC). Parasites - Clonorchis. <a href="https://www.cdc.gov/parasites/clonorchis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/clonorchis/health_professionals/index.html</a>. Updated May 20, 2020i. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.10">
<a name="CDC.10"></a>Centers for Disease Control and Prevention (CDC). Parasites - Echinococcosis. <a href="https://www.cdc.gov/parasites/echinococcosis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/echinococcosis/health_professionals/index.html</a>. Updated May 21, 2020e. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.7">
<a name="CDC.7"></a>Centers for Disease Control and Prevention (CDC). Parasites - Enterobiasis (also known as pinworm infection). <a href="https://www.cdc.gov/parasites/pinworm/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/pinworm/health_professionals/index.html</a>. Updated August 28, 2019c. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.11">
<a name="CDC.11"></a>Centers for Disease Control and Prevention (CDC). Parasites - Gnathostomiasis (Gnathostoma infection). <a href="https://www.cdc.gov/parasites/gnathostoma/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/gnathostoma/health_professionals/index.html</a>. Updated May 22, 2020c. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.12">
<a name="CDC.12"></a>Centers for Disease Control and Prevention (CDC). Parasites - Loiasis. <a href="https://www.cdc.gov/parasites/loiasis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/loiasis/health_professionals/index.html</a>. Updated November 24, 2020f. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.13">
<a name="CDC.13"></a>Centers for Disease Control and Prevention (CDC). Parasites - Opisthorchis infection. <a href="https://www.cdc.gov/parasites/opisthorchis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/opisthorchis/health_professionals/index.html</a>. Updated May 26, 2020j. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.14">
<a name="CDC.14"></a>Centers for Disease Control and Prevention (CDC). Parasites - Toxocariasis (also known as roundworm infection). <a href="https://www.cdc.gov/parasites/toxocariasis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/toxocariasis/health_professionals/index.html</a>. Updated May 26, 2020g. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.15">
<a name="CDC.15"></a>Centers for Disease Control and Prevention (CDC). Parasites - Trichinellosis (also known as Trichinosis). <a href="https://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html</a>. Updated May 26, 2020h. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.16">
<a name="CDC.16"></a>Centers for Disease Control and Prevention (CDC). Parasites - Zoonotic hookworm. <a href="https://www.cdc.gov/parasites/zoonotichookworm/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/zoonotichookworm/health_professionals/index.html</a>. Updated May 26, 2020d. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11498405">
<a name="11498405"></a>Costa SF, Weiss LM. Drug treatment of microsporidiosis. <i>Drug Resist Updat</i>. 2000;3(6):384-399. doi:10.1054/drup.2000.0174<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/11498405/pubmed" id="11498405" target="_blank">11498405</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16818928">
<a name="16818928"></a>Del Brutto OH, Roos KL, Coffey CS, et al, “Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel,” <i>Ann Intern Med</i>, 2006, 145(1):43-51.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/16818928/pubmed" id="16818928" target="_blank">16818928</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9129865">
<a name="9129865"></a>de Silva N, Guyatt H, and Bundy D, “Anthelmintics. A Comparative Review of Their Clinical Pharmacology,” <i>Drugs</i>, 1997, 53(5):769-88.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/9129865/pubmed" id="9129865" target="_blank">9129865</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-MedLet.2013">
<a name="MedLet.2013"></a>Drugs for Parasitic Infections. <i>Med Lett Drugs Ther.</i> 2013. 11(suppl):e1-e31.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19329060">
<a name="19329060"></a>Frazier M, Anderson ML, Sophocleous S. Treatment of ocular toxocariasis with albendezole: a case report. <i>Optometry</i>. 2009;80(4):175-180.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/19329060/pubmed" id="19329060" target="_blank">19329060</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9153484">
<a name="9153484"></a>Garcia HH, Gilman RH, Horton J, et al, “Albendazole therapy for neurocysticercosis: A Prospective Double-Blind Trial Comparing 7 Versus 14 Days of Treatment,” <i>Neurology</i>, 1997, 48(5):1421-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/9153484/pubmed" id="9153484" target="_blank">9153484</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24999157">
<a name="24999157"></a>Garcia HH, Gonzales I, Lescano AG, et al; Cysticercosis Working Group in Peru. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. <i>Lancet Infect Dis</i>. 2014;14(8):687-695. doi: 10.1016/S1473-3099(14)70779-0.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/24999157/pubmed" id="24999157" target="_blank">24999157</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14724304">
<a name="14724304"></a>Garcia HH, Pretell EJ, Gilman RH, “A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis,” <i>N Engl J Med</i>, 2004, 350(3):249-58.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/14724304/pubmed" id="14724304" target="_blank">14724304</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12394823">
<a name="12394823"></a>Gavin PJ, Kazacos KR, Tan TQ, et al. Neural larva migrans caused by the raccoon roundworm Baylisascaris procyonis. <i>Pediatr Infect Dis J</i>. 2002;21(10):971-975. doi:10.1097/00006454-200210000-00017<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/12394823/pubmed" id="12394823" target="_blank">12394823</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36046372">
<a name="36046372"></a>Goldman-Yassen AE, Derman A, Madan RP, Radmanesh A. A worm's tale or why to avoid the raccoon latrine: a case of <i>Baylisascaris procyonis</i> meningoencephalitis. <i>Case Rep Radiol</i>. 2022;2022:5199863. doi:10.1155/2022/5199863<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/36046372/pubmed" id="36046372" target="_blank">36046372</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26960940">
<a name="26960940"></a>Graeff-Teixeira C, Morassutti AL, Kazacos KR. Update on Baylisascariasis, a Highly Pathogenic Zoonotic Infection. <i>Clin Microbiol Rev</i>. 2016;29(2):375-399.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/26960940/pubmed" id="26960940" target="_blank">26960940</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31071321">
<a name="31071321"></a>Gyorkos TW, St-Denis K. Systematic review of exposure to albendazole or mebendazole during pregnancy and effects on maternal and child outcomes, with particular reference to exposure in the first trimester. <i>Int J Parasitol</i>. 2019;49(7):541-554.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/31071321/pubmed" id="31071321" target="_blank">31071321</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21119798">
<a name="21119798"></a>Hajek J, Yau Y, Kertes P, et al. A child with raccoon roundworm meningoencephalitis: A pathogen emerging in your own backyard?. <i>Can J Infect Dis Med Microbiol</i>. 2009;20(4):e177-e180. doi:10.1155/2009/304625<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/21119798/pubmed" id="21119798" target="_blank">21119798</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34190570">
<a name="34190570"></a>Han B, Pan G, Weiss LM. Microsporidiosis in humans. <i>Clin Microbiol Rev</i>. 2021;34(4):e0001020. doi:10.1128/CMR.00010-20<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/34190570/pubmed" id="34190570" target="_blank">34190570</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15680651">
<a name="15680651"></a>Hawk MW, Shahlaie K, Kim KD, and Theis JH, “Neurocysticercosis: A Review,” <i>Surg Neurol</i>, 2005, 63(2):123-32.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15680651/pubmed" id="15680651" target="_blank">15680651</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3516398">
<a name="3516398"></a>Jagota SC. Albendazole, a broad-spectrum anthelmintic, in the treatment of intestinal nematode and cestode infection: a multicenter study in 480 patients. <i>Clin Ther</i>. 1986;8(2):226-231.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/3516398/pubmed" id="3516398" target="_blank">3516398</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25564736">
<a name="25564736"></a>Jee D, Kim KS, Lee WK, Kim W, Jeon S. Clinical features of ocular toxocariasis in adult Korean patients.<i> Ocul Immunol Inflamm.</i> 2016;24(2):207-216. doi: 10.3109/09273948.2014.994783.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/25564736/pubmed" id="25564736" target="_blank">25564736</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10423586">
<a name="10423586"></a>Jung H, Sanchez M, Gonzalez-Astiazaran A, et al, “Clinical Pharmacokinetics of Albendazole in Children With Neurocysticercosis,” <i>Am J Ther</i>, 1997, 4(1):23-6.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/10423586/pubmed" id="10423586" target="_blank">10423586</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15069729">
<a name="15069729"></a>Karabay O, Tamer A, Gunduz H, Kayas D, Arinc H, Celebi H. Albendazole versus metronidazole treatment of adult giardiasis: an open randomized clinical study. <i>World J Gastroenterol.</i> 2004;10(8):1215-1217. doi: 10.3748/wjg.v10.i8.1215.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15069729/pubmed" id="15069729" target="_blank">15069729</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31145496">
<a name="31145496"></a>La Hoz RM, Morris MI; AST Infectious Diseases Community of Practice. Intestinal parasites including cryptosporidium, cyclospora, giardia, and microsporidia, entamoeba histolytica, strongyloides, schistosomiasis, and echinococcus: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. <i>Clin Transplant.</i> 2019;33(9):e13618. doi: 10.1111/ctr.13618.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/31145496/pubmed" id="31145496" target="_blank">31145496</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3396623">
<a name="3396623"></a>Lange H, Eggers R, Bircher J. Increased systemic availability of albendazole when taken with a fatty meal. <i>Eur J Clin Pharmacol</i>. 1988;34(3):315-317.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/3396623/pubmed" id="3396623" target="_blank">3396623</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31641774">
<a name="31641774"></a>Lau R, Chris RB, Phuong MS, et al. Treatment of soil-transmitted helminth infections in pregnancy: a systematic review and meta-analysis of maternal outcomes. <i>J Travel Med.</i> 2020;27(2). doi:10.1093/jtm/taz079<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/31641774/pubmed" id="31641774" target="_blank">31641774</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8602186">
<a name="8602186"></a>Liu LX and Weller PF, “Antiparasitic Drugs,” <i>N Engl J Med</i>, 1996, 334(18):1178-84.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/8602186/pubmed" id="8602186" target="_blank">8602186</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4028809">
<a name="4028809"></a>Misra PK, Pande NK, Jagota SC. Albendazole in the treatment of intestinal helminthiasis in children. <i>Curr Med Res Opin</i>. 1985;9(8):516-519. doi:10.1185/03007998509109627<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/4028809/pubmed" id="4028809" target="_blank">4028809</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28056024">
<a name="28056024"></a>Mofid LS, Casapía M, Aguilar E, et al. A double-blind randomized controlled trial of maternal postpartum deworming to improve infant weight gain in the Peruvian Amazon. <i>PLoS Negl Trop Dis</i>. 2017;11(1):e0005098.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/28056024/pubmed" id="28056024" target="_blank">28056024</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12745139">
<a name="12745139"></a>Montresor A, Awasthi S, Crompton DW. Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis. <i>Acta Trop</i>. 2003;86(2-3):223-232. doi:10.1016/s0001-706x(03)00042-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/12745139/pubmed" id="12745139" target="_blank">12745139</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15546085">
<a name="15546085"></a>Murray WJ, Kazacos KR. Raccoon roundworm encephalitis. <i>Clin Infect Dis</i>. 2004;39(10):1484-1492.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15546085/pubmed" id="15546085" target="_blank">15546085</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17553240">
<a name="17553240"></a>Pai PJ, Blackburn BG, Kazacos KR, Warrier RP, Bégué RE. Full recovery from Baylisascaris procyonis eosinophilic meningitis. <i>Emerg Infect Dis</i>. 2007;13(6):928-930.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/17553240/pubmed" id="17553240" target="_blank">17553240</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20176353">
<a name="20176353"></a>Pallua K, Putz G, Mitterschiffthaler G, Brezinka C, Biebl M, Paal P. Management of hepatic echinococcosis in pregnancy. <i>Int J Gynaecol Obstet</i>. 2010;109(2):162.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/20176353/pubmed" id="20176353" target="_blank">20176353</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-PAHO.1">
<a name="PAHO.1"></a>Pan American Health Organization (PAHO). Guideline for the preventive chemotherapy for the control of Taenia solium Taeniasis. https://iris.paho.org/bitstream/handle/10665.2/54800/9789275123720_eng.pdf?sequence=1&amp;isAllowed=y. Updated September 2021. Accessed August 31, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11015551">
<a name="11015551"></a>Park SY, Glaser C, Murray WJ, et al. Raccoon roundworm (Baylisascaris procyonis) encephalitis: case report and field investigation. <i>Pediatrics</i>. 2000;106(4):E56.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/11015551/pubmed" id="11015551" target="_blank">11015551</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29790912">
<a name="29790912"></a>Persichino JG, Miller LG. Pregnancy screening and monitoring of albendazole therapy for neurocysticercosis. <i>Clin Infect Dis</i>. 2018;67(11):1797-1798.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/29790912/pubmed" id="29790912" target="_blank">29790912</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22311989">
<a name="22311989"></a>Peters JM, Madhavan VL, Kazacos KR, Husson RN, Dangoudoubiyam S, Soul JS. Good outcome with early empiric treatment of neural larva migrans due to Baylisascaris procyonis. <i>Pediatrics</i>. 2012;129(3):e806-811.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/22311989/pubmed" id="22311989" target="_blank">22311989</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26087057">
<a name="26087057"></a>Salam RA, Haider BA, Humayun Q, Bhutta ZA. Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy. <i>Cochrane Database Syst Rev</i>. 2015;(6):CD005547.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/26087057/pubmed" id="26087057" target="_blank">26087057</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10548302">
<a name="10548302"></a>Sawamura R, Fernandes MI, Peres LC, et al. Hepatic capillariasis in children: report of 3 cases in Brazil. <i>Am J Trop Med Hyg</i>. 1999;61(4):642-647.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/10548302/pubmed" id="10548302" target="_blank">10548302</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26538729">
<a name="26538729"></a>Siddalingappa K, Murthy SC, Herakal K, Kusuma MR. Cutaneous larva migrans in early infancy. <i>Indian J Dermatol</i>. 2015;60(5):522. doi:10.4103/0019-5154.164436<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/26538729/pubmed" id="26538729" target="_blank">26538729</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27847893">
<a name="27847893"></a>Siddiqui B, Faridi SH, Arif SH, Aslam M. Primary hydatid disease of the breast clinically masquerading as a galactocele: a case report. <i>J Transl Int Med</i>. 2015;3(2):82-84.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/27847893/pubmed" id="27847893" target="_blank">27847893</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14523772">
<a name="14523772"></a>Smego, RA, Bhatti S, Khaliq AA, et al, “Percutaneous Aspiration-Injection-Reaspiration Drainage Plus Albendazole or Mebendazole for Hepatic Cystic Echinococcosis: A Meta-Analysis,” <i>Clin Infect Dis</i>, 2003, 37(8):1073-83.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/14523772/pubmed" id="14523772" target="_blank">14523772</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21980373">
<a name="21980373"></a>Steinmann P, Utzinger J, Du ZW, et al. Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial. <i>PLoS One</i>. 2011;6(9):e25003. doi: 10.1371/journal.pone.0025003.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/21980373/pubmed" id="21980373" target="_blank">21980373</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24278060">
<a name="24278060"></a>Tekely E, Szostakiewicz B, Wawrzycki B, et al. Cutaneous larva migrans syndrome: a case report. <i>Postepy Dermatol Alergol</i>. 2013;30(2):119-121. doi:10.5114/pdia.2013.34164<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/24278060/pubmed" id="24278060" target="_blank">24278060</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30231902">
<a name="30231902"></a>Tianyi FL, Agbor VN, Kadia BM, Dimala CA. An unusual case of extensive truncal cutaneous larva migrans in a Cameroonian baby: a case report. <i>J Med Case Rep</i>. 2018;12(1):270. doi:10.1186/s13256-018-1792-y<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/30231902/pubmed" id="30231902" target="_blank">30231902</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15602190">
<a name="15602190"></a>Tremoulet AH, Avila-Aquero ML, Paris MM, Canas-Coto A, Ulloa-Gutierrez R, Faingezicht I. Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. <i>Pediatr Inf Dis J</i>. 2004;23(10):915-918.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15602190/pubmed" id="15602190" target="_blank">15602190</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-HHS.1">
<a name="HHS.1"></a>US Department of Health and Human Services (HHS) Panel on Adult and Adolescent Opportunistic Infection. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. <a href="https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new" target="_blank">https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new</a>. Updated November 21, 2019. Accessed January 22, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-HHS.4">
<a name="HHS.4"></a>US Department of Health and Human Services (HHS) Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. <a href="https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/whats-new" target="_blank">https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/whats-new</a>. Updated September 14, 2023. Accessed October 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29481580">
<a name="29481580"></a>White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). <i>Clin Infect Dis</i>. 2018;66(8):e49-e75. doi: 10.1093/cid/cix1084.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/29481580/pubmed" id="29481580" target="_blank">29481580</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29790917">
<a name="29790917"></a>White AC Jr, Coyle CM, Rajshekhar V, et al. Reply to Garg et al, Smith et al, and Persichino and Miller. <i>Clin Infect Dis</i>. 2018;67(11):1798.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/29790917/pubmed" id="29790917" target="_blank">29790917</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11303277">
<a name="11303277"></a>Wilson ME, Lorente CA, Allen JE, et al, “Gongylonema Infection of the Mouth in a Resident of Cambridge, Massachusetts,” <i>Clin Infect Dis</i>, 2001, 32(9):1378-80.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/11303277/pubmed" id="11303277" target="_blank">11303277</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.1">
<a name="WHO.1"></a>World Health Organization (WHO). Action against worms N<sup>o</sup> 8: deworming young children. 2007. Available at https://www.who.int/publications/i/item/WHO-HTM-NTD-PCT-2007.3
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.2">
<a name="WHO.2"></a>World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the eleventh WHO model list of essential drugs. 2002. Available at http://www.who.int/maternal_child_adolescent/documents/55732/en/
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.3">
<a name="WHO.3"></a>World Health Organization (WHO). Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. Geneva: World Health Organization; 2017. Available at https://www.who.int/intestinal_worms/resources/9789241550116/en/
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.4">
<a name="WHO.4"></a>World Health Organization (WHO). Report of the informal consultation on hookworm infection and anaemia in girls and women. 1996. Available at https://www.who.int/intestinal_worms/resources/who_ctd_sip_96.1/en/
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34520139">
<a name="34520139"></a>World Health Organization (WHO). WHO guidelines on management of Taenia solium neurocysticercosis. Geneva: World Health Organization; 2021.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/34520139/pubmed" id="34520139" target="_blank">34520139</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.5">
<a name="WHO.5"></a>World Health Organization (WHO). WHO Model Formulary for Children. 2010.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15191380">
<a name="15191380"></a>Yereli K, Balcioğlu IC, Ertan P, et al, "Albendazole as an Alternative Therapeutic Agent for Childhood Giardiasis in Turkey," <i>Clin Microbiol Infect</i>, 2004, 10(6):527-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15191380/pubmed" id="15191380" target="_blank">15191380</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30959248">
<a name="30959248"></a>Zhang B, Wei L, Ma L. A case of cutaneous larva migrans. <i>Int J Infect Dis</i>. 2019;83:44-45. doi:10.1016/j.ijid.2019.04.003<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/30959248/pubmed" id="30959248" target="_blank">30959248</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15228719">
<a name="15228719"></a>Ziem JB, Kettenis IM, Bayita A, et al, "The Short-Term Impact of Albendazole Treatment on <i>Oesophagostomum bifurcum</i> and Hookworm Infections in Northern Ghana," <i>Ann Trop Med Parasitol</i>, 2004, 98(4):385-90.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/albendazole-drug-information/abstract-text/15228719/pubmed" id="15228719" target="_blank">15228719</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9371 Version 270.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
